Zimmer Biomet: Adding To The Growth Profile

Core Insights - Zimmer Biomet's shares declined to $105 in September, indicating potential value despite projected mid-single digit sales growth, improved cash flows, and higher earnings growth driven by recent M&A activities [1] Group 1: Company Performance - The company is expected to achieve mid-single digit sales growth [1] - Improved cash flows and higher earnings growth are anticipated due to recent mergers and acquisitions [1] Group 2: Investment Opportunities - The investing group "Value In Corporate Events" focuses on identifying opportunities in IPOs, mergers & acquisitions, earnings reports, and changes in corporate capital allocation [1] - The group covers 10 major events monthly to find the best investment opportunities [1]